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Abstract
Background: The costs of arm, shoulder and neck symptoms are high. In order to decrease these costs employers
implement interventions aimed at reducing these symptoms. One frequently used intervention is the RSI
QuickScan intervention programme. It establishes a risk profile of the target population and subsequently advises
interventions following a decision tree based on that risk profile. The purpose of this study was to perform an
economic evaluation, from both the societal and companies’ perspective, of the RSI QuickScan intervention
programme for computer workers. In this study, effectiveness was defined at three levels: exposure to risk factors,
prevalence of arm, shoulder and neck symptoms, and days of sick leave.
Methods: The economic evaluation was conducted alongside a randomised controlled trial (RCT). Participating
computer workers from 7 companies (N = 638) were assigned to either the intervention group (N = 320) or the
usual care group (N = 318) by means of cluster randomisation (N = 50). The intervention consisted of a tailor-made
programme, based on a previously established risk profile. At baseline, 6 and 12 month follow-up, the participants
completed the RSI QuickScan questionnaire. Analyses to estimate the effect of the intervention were done
according to the intention-to-treat principle. To compare costs between groups, confidence intervals for cost
differences were computed by bias-corrected and accelerated bootstrapping.
Results: The mean intervention costs, paid by the employer, were 59 euro per participant in the intervention and
28 euro in the usual care group. Mean total health care and non-health care costs per participant were 108 euro in
both groups. As to the cost-effectiveness, improvement in received information on healthy computer use as well
as in their work posture and movement was observed at higher costs. With regard to the other risk factors,
symptoms and sick leave, only small and non-significant effects were found.
Conclusions: In this study, the RSI QuickScan intervention programme did not prove to be cost-effective from the
both the societal and companies’ perspective and, therefore, this study does not provide a financial reason for
implementing this intervention. However, with a relatively small investment, the programme did increase the
number of workers who received information on healthy computer use and improved their work posture and
movement.
Trial registration: Trial registration number: NTR1117.
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The costs of musculoskeletal disorders are high, with
conservative estimates of the economic burden imposed
to the U.S. economy, as measured by compensation
costs, lost wages, and lost productivity, between 45 and
54 billion US dollar annually, equalling approximately
0.8% of the gross domestic product [1]. Available cost
estimates of musculoskeletal disorders from 15 European
countries put the cost between 0.5% and 2% of their
gross domestic products[2]. These costs include lost pro-
duction, staff sickness, compensation and insurance
costs, losing experienced staff and recruiting and training
new staff, and the effect of discomfort or ill health on the
quality of work [2].
Work-related arm, shoulder and neck symptoms are
common in Europe, with 25% of the workers reporting
work-related neck/shoulder pain, and 15% reporting
work-related arm pain[2]. Amongst computer workers,
the prevalence of neck, shoulder and arm symptoms is
high and cross-sectional studies have reported preva-
lence rates between 10 and 62% [3]. The total yearly
costs of arm, shoulder and neck symptoms in the
Netherlands due to decreased productivity, sick leave,
chronic disability for work and medical costs were esti-
mated at 2.1 billion Euros [4].
To reduce these costs employers implement interven-
tions aimed at reducing these symptoms. One frequently
used intervention, which has recently been developed by
an occupational health service in the Netherlands, is the
RSI QuickScan intervention programme for computer
workers. This multidimensional intervention program
addresses a broad spectrum of potential risk factors. It
consists of a questionnaire that generates a specific risk
profile of the target population, followed by a decision
tree for selecting tailor-made interventions [5,6]. The key
cost of the this program are the costs of purchasing the
questionnaire and costs of implementing interventions,
such as an information or training session, a visit to the
occupational physician, an eyesight test, an individual
workplace assessment or a task analysis.
Even though interventions aimed at reducing arm,
shoulder and neck symptoms are often used, there is a
shortage of high quality studies evaluating the cost-
effectiveness of these interventions [7]. Two recent
reviews evaluating the effectiveness of preventive inter-
ventions did not find strong evidence for the effective-
ness of interventions and were, therefore, hesitant to
give policy recommendations [8,9]. A recent systematic
review by Brewer et al [8] observed a mixed level of evi-
dence for the general question “Do office interventions
among computer users have an effect on musculoskele-
t a lo rv i s u a lh e a l t h ? ”. Moderate evidence was observed
for: (1) no effect of workstation adjustment, (2) no effect
of rest breaks and exercise, and (3) a positive effect of
alternative pointing devices. A systematic review by Boo-
cock et al [9], on interventions for the prevention and
management of neck/upper extremity musculoskeletal
conditions, found moderate evidence for changes to
workstation equipment and some evidence that multiple
modifier interventions including or excluding exercise
can have positive effects in computer workers with arm,
shoulder and neck symptoms.
Because resources to achieve the desired positive
effects are often scarce, employers and policy makers
need to choose the most cost-effective intervention.
This has caused a rapid expansion of research on the
economics of occupational health in recent years [10].
To be able to make evidence-based choices on which
interventions to implement, reliable information is
required on both costs and benefits of interventions.
Economic evaluations aim to provide this information.
T h eo b j e c t i v eo ft h i ss t u d yw a st oe v a l u a t et h ec o s t -
effectiveness and cost-benefits, from both the societal
and companies’ perspective of the RSI QuickScan inter-
vention programme for computer workers.
Methods
Design and study population
This economic evaluation was conducted alongside a clus-
ter Randomised Controlled Trial (RCT). Measurements
took place at baseline, after 6-months and 12-months.
Cost-effectiveness was determined after 12 months.
Although the underlying mechanisms for neck, shoulder
and arm symptoms are still poorly understood [11], inter-
vention studies [12,13] and clinical trials [14,15] that
proved to be effective suggest that interventions might be
effective on short term, i.e. within 6 months.
The study population consisted of computer workers
from 7 Dutch organizations in various branches, in dif-
ferent regions of the Netherlands. Workers with and
without arm, shoulder and neck symptoms were
included. Of the 1,673 persons who were invited to par-
ticipate in the study, 1,183 persons (71%) completed the
baseline questionnaire. A total of 638 persons (54%) par-
ticipated at baseline as well as at 6- and 12-months fol-
low-up and were included in the statistical analyses.
The study design, protocols, procedures and informed
consent form were approved by the Ethics Committee
of the Faculty of Human Movement Sciences of the VU
University Amsterdam, and all participants electronically
provided informed consent before filling out the baseline
questionnaire.
The methodological details of the trial are reported in
full elsewhere [6].
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The participants were assigned to either the interven-
tion group or the usual care group by means of cluster
randomisation (N = 50). To prevent unbalanced rando-
misation, workers were pre-stratified by the Human
Resource Management (HRM) departments of the par-
ticipating organizations. Organizations were asked to
form clusters of approximately the same size and with
a comparable amount of computer work. Teams or
departments were left intact to avoid crossover effects
and to enhance compliance within the intervention
groups. The clusters from each organisation were ran-
domly divided into an intervention group and a usual
care group. Participants were not informed about their
allocation.
Data collection
At baseline, 6- and 12-months follow-up, the workers
completed the internet-based RSI QuickScan question-
naire [5] on exposure to risk factors, and the 7-days and
6-months prevalence of arm, shoulder and neck symp-
toms. The RSI QuickScan investigates the presence or
absence of potential risk factors, such as work posture
and movement, job decision latitude, relation with man-
agement and colleagues, work pace and load, work
environment factors, and furniture. A detailed descrip-
tion of the questionnaire can be found at additional file
1: http://www.rsiquickscan.com/research/questionnaire.
pdf . For this study, supplementary questions on the use
of medical, alternative care resources and the use of
pain medication were added.
Intervention group
The intervention group received full feedback on their
RSI QuickScan questionnaire results. This feedback con-
sisted of scores on a scale from 1 to 10, an interpretation
of the score and elaborate advice on the specific actions
that they could personally take in order to reduce expo-
sure to risk factors. If workers reported severe symptoms
in the arm, shoulder and neck region, their occupational
physician invited them for a consultation. Furthermore,
from the information given by the respondents, a risk
profile was made, using a traffic light risk assessment sys-
tem. The risk profile was compiled also for each cluster.
If more than 30% of the participants in a cluster had a
red score or more than 60% of the participants in a clus-
ter had a red or amber score on a certain risk factor, a
tailor-made intervention programme was proposed. Per
risk factor a (set of) intervention(s) to be advised to the
participating organizations was pre-defined.
A set of 16 interventions aimed at reducing the risk
factors in the RSI QuickScan was available. Examples of
proposed interventions were: at the individual level: an
individual workstation check and an eyesight check; at
the group level: an education programme on the preven-
tion of arm, shoulder and neck symptoms and training
on handling stress in the workplace. A description of all
interventions can be found at additional file 2: http://
www.rsiquickscan.com/research/interventions.pdf.
Usual care group
The usual care group did not receive elaborate advice
on the specific actions that they could personally take
after completing the RSI QuickScan, but more general
and limited advice. Furthermore, they did not receive
interventions based on the risk profile during the time
of the study. Given ethical considerations, workers who
reported severe symptoms in the arm, shoulder and
neck region, 35 cases in this group, were invited by
their occupational physician for a consultation. For
other supplementary actions the usual care group was
put on a waiting list. Consequently, the usual care group
received interventions that were similar to those in the
intervention group, but only after the study had ended.
Outcome measures
For the economic evaluation, the outcome measures
were the same as those in the study evaluating the effec-
tiveness of the RSI QuickScan[6], namely, exposure to
risk factors [5], the prevalence of arm, shoulder and
neck symptoms, and the number of days of sick leave.
The prevalence of arm, shoulder and neck symptoms
was estimated with the questionnaire, which specified 7
areas in the arm, shoulder and neck region. The total
symptom score was a continuous measure that consisted
of the sum of points scored on the scale arm, shoulder
and neck symptoms.
Sick leave was assessed for the 6-month period prior
to baseline, and for 6- and 12-month follow-up. This
information was gathered from company records pro-
vided by the HRM Department, with the advantage of
good coverage, accuracy and consistency [16]. The data
consisted of total sick leave, maternity leave excluded,
and not solely sick leave due to arm, shoulder and neck
symptoms.
Cost measurement and valuation
Cost-effectiveness analyses were conducted from both
the employers’ perspective and the societal perspective.
The workers use of medical, alternative care resources
and the use of pain medication were measured at baseline
and at 6- and 12-month follow-up, using an online ques-
tionnaire. These data were used to calculate the direct
costs of neck, shoulder and arm symptoms. In the online
questionnaire, the workers were asked whether they had
used pain medication, anti-inflammatory drugs or a com-
bination of both, due to neck, shoulder and arm symp-
toms, but not what kind or how many. These costs were
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tivity analysis. The costs of 40 tablets of pain medication,
anti-inflammatory drugs or a combination of both, were
imputed for workers who had used these drugs in the
past 6-months period. The costs of visits to a general
practitioner, medical specialist and physiotherapist were
estimated according to the Dutch manual for costing in
economic evaluations [17] and were indexed for 2006,
the year in which the trial was performed (Table 1).
Other intervention costs, such as the costs of the ques-
tionnaire, training and visit to the occupational physician,
were provided by the Occupational Health Service and
their commercial prices were applied. Costs were deter-
mined by multiplying the volume reported on each cost
by the estimated costs per unit. An overview of these
costs per unit can be found in Table 1. The costs of pri-
vate purchases of specific products/tools aimed at redu-
cing neck, shoulder and arm symptoms were taken into
account. This information was derived from the ques-
tionnaire by two specific questions about this topic. Since
these costs may be underreported and are therefore sub-
ject to some uncertainty, the effects of a 500% increase of
these costs were estimated in a sensitivity analysis. Indir-
ect costs of productivity loss were also taken into
account. These costs are not related to health care, but
are costs as a consequence of these symptoms, such as
sick leave of productive persons in paid labour. Indirect
costs caused by production losses were estimated using
the friction cost approach, which assumes that costs are
limited to the friction period (i.e. the time it takes to find
a replacement), and that the decrease in productivity is
less than 100% of the time lost at work (i.e. elasticity)
[18]. The friction period was estimated to be 154 calen-
dar days and an elasticity of 0.8 was used [18]. Calcula-
tions were based on a mean income of the Dutch
working population and indexed for 2006, according to
age and gender [17].
Statistical analysis
Only workers who completed all three measurements
and questionnaires were included in the analyses. Ana-
lyses to estimate the effect of the intervention were
done according to the intention-to-treat principle [19].
Resource use, sick leave and costs were calculated per
person for the 12-months follow-up period.
Cost data are usually skewed to the right [20]. To com-
pare costs between groups, confidence intervals for cost
differences were computed by bias-corrected and acceler-
ated (BCa) bootstrapping with 2000 replications [21].
Non-parametric bootstrapping is often used to analyze
cost data, because decision makers need to be able to
link the summary measure of cost per person to the over-
all budget impact and this can only be achieved by the
mean [22]. The scores were, therefore, expressed as the
mean costs per person for the intervention and usual
care group and the difference in mean costs between
both groups over 12 months. Costs for paid labour were
adjusted for 2006 values.
Cost-effectiveness analysis relates the difference in
costs between the intervention and the usual care groups
to the difference in effects. A cost-effectiveness analysis
was performed on the two risk factors (“information” and
“work posture and movement”) that showed a significant
positive change in the randomized controlled trial asses-
sing the effects of the RSI QuickScan and on two factors
that did not show a significant positive change, “arm,
neck, shoulder symptoms” and the number of “days of
sick leave”[6]. For the cost-effectiveness analysis, effect
scores on the scales “information”, “work posture and
movement” and “arm, neck, shoulder symptoms” were
adjusted for baseline. In this analysis, we used the total
costs for the outcomes risk factors and prevalence.
In a cost-benefit analysis the effects are expressed as
benefits in monetary units. The difference in the mone-
tary costs due to sick leave between the intervention
group and the usual care group was calculated. For the
cost-effectiveness and cost-benefit analyses, the number
of days and costs of sick leave were calculated for
the half year period, starting 6-months prior to the last
Table 1 Prices used in the economic evaluation
€ (2006
values)
1
Direct health care costs
- General practitioner [per visit]
2 21.03
- Medical specialist [per visit]
2 102.01
- Physiotherapist and alternative therapist [per visit]
2 23.68
- Occupational physiotherapist (1 hour)
3 121.50
- Occupational psychologist (1 hour)
3 126.50
- Occupational physician (20 min)
3 70.00
Direct non-health care costs
Purchased products aimed at reducing symptoms
(range costs)
0-5 0
Intervention costs
- RSI Quickscan - questionnaire
3 15.00
- Information session ‘Computer work and RSI’
3 30.00
- Training RSI and Stress
3 90.00
- Consult occupational physician (20 min)
3 70.00
- Eyesight test
3 20.00
- Individual workplace assessment
3 330.00
- Task analyses
3 60.00
Indirect costs
Sick leave from paid labour (range costs per hour)
2 20.89 - 49.78
1 € = US $ 1.27;
2 prices according to “Standardisation of costs: the Dutch
manual for costing in economic evaluations”, Oostenbrink, 2004. Indirect costs
for paid labour were calculated according to the friction cost approach on the
basis of the mean income of the Dutch population stratified for age and
gender [17];
3 prices according to the professional organisation (Occupational
Health Service - Arbo Unie).
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6-months prior to baseline. For the cost-effectiveness
analysis of the outcome sick leave from a societal per-
spective, only the direct costs were included to avoid
double counting. From the companies’ perspective, sick
leave is a real expense in the Netherlands where the
employer pays 100% of the wage during the first year of
sick leave, We included indirect costs of sick leave as
benefit in the cost-benefit analysis performed from the
companies’ perspective.
To estimate the incremental cost-effectiveness ratio
(ICER), we divided the incremental costs of the interven-
tion group compared with those of the usual care group
by the incremental effects for each of the effect measures
separately. The uncertainty associated with the incremen-
tal cost-effectiveness ratios was analysed by bootstrap-
ping using the bias-corrected percentile method with
5000 replications [23]. The bootstrapped incremental
cost/effect pairs were plotted on a cost-effectiveness
plane [24], consisting of four quadrants with a horizontal
axis indicating the effectiveness of the intervention in
relation to the usual care group and the vertical axis indi-
cating the difference in costs between the groups.
Sensitivity analyses were performed in which missing
cost data for medicine use were imputed and the costs
of private purchases of specific products/tools was
increased.
Results
Resource use and costs
In both groups, resource utilization was low and there
were no significant differences between the two groups
(Table 2). Physical and alternative therapy were the
most frequently used health care resources in both
groups, with the highest cost. Approximately 14% of the
participants in the study purchased products aimed at
reducing symptoms, such as a special computer mouse.
However, the mean costs of these products were low
compared to the other direct costs, especially compared
to sick leave (Table 2).
Intervention use and costs
The utilization rates (%) of interventions during the
12-months follow-up period are given in Table 3. All
participants, regardless of group allocation, received the
RSI QuickScan. There were significant between-group
differences in utilization rates for the “Education on the
Prevention of RSI for Employees”, the training “RSI and
Stress”, the eyesight check, and task analysis (Table 3).
The total mean costs of the interventions were €58.97
and €28.24 in the intervention and usual care group,
respectively (Table 4 and 5).
In both groups, the main contributor to the total
direct costs were the total non-health and health care
costs, which were slightly, but not significant, higher in
the intervention group (Table 4). There was a significant
difference in total intervention costs. However, there
was no significant difference in total direct costs, which
is the sum of all intervention, non-health and health
care costs (Table 4).
Cost-effectiveness
The mean societal costs and effects per person over
12 months for the scales “information”, “work posture
and movement” and “arm, neck, shoulder symptoms”
show a significant positive effect for the intervention
group on received information on healthy computer use
and on work posture and movement, with a relatively
small difference in total direct costs between the groups
(Table 6). The reduction of arm, neck and shoulder
symptoms was more prominent in the intervention
group, but not significantly so (Table 6). Days and costs
of sick leave were higher in the intervention group.
However, it is important to note that the effects and
benefits were highly non-significant, as can be derived
from the 95% confidence interval of the difference in
days and costs of sick leave (Table 6).
The cost-effectiveness ratio (ICER) for “information”
was estimated at -277.58, indicating that the cost of one
point of improvement, which in this case is a negative
score since it is a reduction in risk, on a scale ranging
from 0 (did receive information on healthy computer
use) to 1 (did not receive information on healthy com-
puter use) was estimated at €277.58.
The intervention is significantly more effective with
85% of the incremental cost/effect pairs located in the
northeast quadrant and 15% in the southeast quadrant
of the cost-effectiveness plane (Figure 1).
The cost-effectiveness ratio (ICER) for “work posture
and movement” was estimated at -93.82, indicating a
cost of €93.82 for one point improvement on a scale
ranging from 0 (perfect work posture and movement) to
11 (poor work posture and movement). The interven-
tion was significantly more effective with 86% of the
incremental cost/effect pairs located in the northeast
quadrant and 13% in the southeast quadrant of the cost-
effectiveness plane (Figure 2).
The cost-effectiveness ratio (ICER) for “the prevalence
of arm, shoulder and neck symptoms” indicated that the
cost of one point reduction in arm, shoulder and neck
symptoms, on a scale ranging from 0 (no arm, shoulder
and neck symptoms) to 44 (severe arm, shoulder and
neck symptoms) was estimated at €72.55. The interven-
tion was more effective with 87% of the incremental cost/
effect pairs located in the northeast quadrant, 8% in the
northwest quadrant, 5% in the southeast quadrant and
0% in the southwest quadrant of the cost-effectiveness
plane (Figure 3).
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leave” indicated that an investment of €71.31 is asso-
ciated with in an increase of sick leave by one day.
Hence, the intervention was generally less effective with
40% of the incremental cost/effect pairs located in the
east quadrants, 61% in the west quadrants of the cost-
effectiveness plane (Figure 4). This is, of course, an
undesired effect. However, it is important to note that
the effect is highly non-significant, as can be seen from
the costs-effectiveness plane and the 95% confidence
interval of the difference in sick leave days, which ranges
from -3.26 to 4.14 (Table 6).
Cost-benefit
The cost-effectiveness ratio (ICER) per point change in
cost of sick leave is estimated at €0.39, which means
that an investment of €0.39 is associated with an €1
increase of sick leave costs. Obviously, this is an unde-
sirable, but highly non-significant, effect as can be seen
from the cost-effectiveness plane (Figure 5), which had
34% of the incremental cost/effect pairs located in the
east quadrants, 66% in the west quadrants and the 95%
confidence of the difference in sick leave costs (Table 6).
Sensitivity analysis
Imputation of missing cost data for medicine use
increased the costs in the usual care group by €1.42 (SD =
4.45) and in the intervention group by €1.38 (SD = 4.25).
The imputation of missing cost data led to a mean differ-
ence of €31.02 (95% CI -32.32 to 76.43) in total costs.
Increasing the costs of private purchases of specific
products/tools, aimed at reducing neck, shoulder and
arm symptoms, by 500% increased the cost in the usual
care group to €0.16 (SD = 2.80) and in the intervention
group to €0.78 (SD = 13.98). The imputation of missing
cost data led to a mean difference of €31.60 (95% CI
-19.57 to 84.30) in total costs.
Discussion
This study evaluated the cost-effectiveness and cost-
benefits of the RSI QuickScan intervention programme
on exposure to risk factors, prevalence of arm, shoulder
Table 2 Utilization, costs and differences in costs during the 12-months follow-up period
Resource use and costs Intervention
(n = 320)
Mean (SD)
Usual care
(n = 318)
Mean (SD)
Intervention - Usual care
Difference in costs
Mean (95% CI)
General practitioner
- no of visits 0.37 (1.43) 0.43 (1.39)
- costs
2 7.69 (30.12) 9.12 (29.22) -1.44 (-6.05; 3.18)
Medical specialist
- no of visits 0.25 (1.37) 0.28 (1.26)
- costs
2 25.50 (140.14) 28.55 (128.38) -3.05 (-23.95; 17.85)
Physical and alternative therapist
- no of treatment sessions 1.71 (5.68) 1.65 (4.89)
- costs
2 40.55 (134.50) 39.02 (115.81) 1.53 (-17.99; 21.05)
Occupational psychologist
- no of treatment sessions 0.02 (0.21) 0.00 (0.06)
- costs
3 2.37 (26.39) 0.40 (7.09) 1.97 (-1.03; 4.98)
Occupational physiotherapy
- no of treatment sessions 0.17 (1.61) 0.18 (1.06)
- costs
3 23.92 (195.11) 21.78 (128.17) 2.14 (-23.54; 27.82)
Occupational health physician
- no of visits 0.11 (0.68) 0.12 (0.67)
- costs
3 7.66 (47.87) 8.59 (46.89) -0.93 (-8.30; 6.44)
Purchased products aimed at
reducing symptoms
- % yes 14 11
- costs 0.16 (2.30) 0.03 (0.56) 0.13 (-0.19; 0.44)
Sick leave from paid labour
- no of days 10.38 (21.31) 12.50 (25.25)
- costs
2 1768.18 (3686.11) 2090.78 (4303.91) -322.60 (-945.48; 300.28)
Utilization, costs and differences in costs (€, 2006 values
1) of health care, non-health care resources and sick leave per person in the intervention and usual care
group during the 12-months follow-up period.
1 € = US $ 1.27;
2 prices according to “Standardisation of costs: the Dutch manual for costing in economic
evaluations”, Oostenbrink, 2004. Indirect costs for paid labour were calculated according to the friction cost approach on the basis of the mean income of the
Dutch working population stratified for age and gender [17];
3 prices according to the professional organisation (Occupational Health Service - Arbo Unie).
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This economic evaluation was performed alongside a
cluster randomized trial [6]. The intervention was not
cost-effective compared to usual care.
Resource use and costs
The results show only small and non-significant differ-
ences between the two groups in the total health and
non-health care resource use and corresponding costs
(€0.36) after 12 months follow-up (Table 4). As expected,
resource use and costs of the interventions were sig-
nificantly higher (€30.73) in the intervention group
compared to the usual care group. Total direct costs
were higher (€31.08) in the intervention group, but the
difference was not significant. In this study, indirect costs
due to sick leave was an outcome measure. The cost-
effectiveness results in this study are primarily viewed
from a societal perspective, because this is the broadest
perspective where all costs and effects are taken into
account, regardless of who benefits from the health
effects or who pays for the costs. However, the cost-
effectiveness from an employer’s perspective, which is
highly relevant to decision makers in organizations, can
also be derived from the results presented.
Table 3 Utilization rates of interventions, mean intervention costs
2 per person and the difference in mean costs
Type of utilization Intervention
(n = 320)
Usual care
(n = 318)
p-value Intervention - Usual care
Difference in costs
Mean (95% CI)
RSI QuickScan
3
- utilization rate (% yes) 100 100
- Mean costs 15.00 15.00 . 0
Occupational health physician
- utilization rate (% yes) 7.8 6.0 0.36
- Mean costs (SD) 5.90 (21.00) 4.40 (17.90) 1.50 (-1.53; 4.54)
Education on the Prevention
of RSI for Employees
- utilization rate (% yes) 26.3 0.3 0.00
- Mean costs (SD) 7.88 (13.22) 0.09 (1.68) 7.81 (6.31; 9.25)
RSI and Stress
- utilization rate (% yes) 24.1 1.9 0.00
- Mean costs (SD) 14.34 (32.99) 1.13 (10.04) 13.21 (9.42; 17.01)
Eyesight check
- utilization rate (% yes) 18.8 6.9 0.00
- Mean costs (SD) 3.75 (7.82) 1.38 (5.08) 2.37 (1.34; 3.39)
Individual Workstation Check
- utilization rate (% yes) 2.2 0.9 0.21
- Mean costs (SD) 11.34 (60.22) 6.23 (44.97) 5.12 (-3.15; 13.84)
Task analyses
- utilization rate (% yes) 1.3 0.0 0.05
- Mean costs (SD) 0.75 (6.68) 0.00 (0.00) 0.75 (0.02; 1.49)
Utilization rates (%) of interventions, mean intervention costs
2 per person and the difference in mean costs (€, 2006 values
1) between the intervention and usual
care groups during the 12-months follow-up period.
1 € =U S$1 . 2 7 ;
2 prices according to the professional organisation (Occupational Health Service - Arbo
Unie);
3 Since there is no variation in intervention costs within the groups, SDs and 95% confidence intervals can not be calculated.
Table 4 Mean costs for the intervention and usual care group and the difference in mean costs from a societal
perspective
Costs Intervention (n = 320)
Mean (SD)
Usual care (n = 318)
Mean (SD)
Intervention - Usual care
Difference in costs
Mean (95% CI)
2
Total intervention costs
3 58.97 (84.74) 28.24 (56.11) 30.73 (18.78; 41.03)
Total non-health and health care costs
4 107.85 (426.32)
_________________+
107.49 (284.68)
_________________+
0.36 (-60.77; 53.04)
____________________+
Total direct costs 166.82 (436.96) 135.73 (294.55) 31.08 (-22.02; 80.27)
Mean costs per person for the intervention and usual care group and the difference in mean costs (€, 2006 values
1) between both groups over 12 months.
1 € = US $1.27;
2 95% confidence interval obtained by bias-corrected and accelerated bootstrapping with 2000 replications;
3 prices according to the professional
organisation (Occupational Health Service - Arbo Unie); 4 prices according to “Standardisation of costs: the Dutch manual for costing in economic evaluations”,
Oostenbrink, 2004.
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Page 7 of 13The overall conclusion is that results of the cost-
effectiveness analysis performed from a societal per-
spective are similar to the results of the cost-benefit
analysis performed from a companies’ perspective. This
is due to the fact that there was only a small difference
in total non-health and health care costs between the
intervention and usual care group of 0.36 euro. From a
societal perspective the difference in total direct costs
between the usual care and intervention group was
31.08 Euro and from the employer’s perspective the
difference in total direct costs between the usual care
and intervention group was 30.73 Euro.
The monetary investments for the interventions that
have to be made by the employer are estimated at
€58.97 per person. This investment resulted in an
increase in sick leave days and sick leave costs and,
therefore, this intervention was not cost-effective.
Limitations of the study
The costs of work-related arm, shoulder and neck symp-
toms and corresponding sick leave in computer workers
are high. One of the major reasons why organizations
implement interventions is to decrease these costs [25].
However, the effect of the intervention depends largely
on a successful implementation by the management and
whether employees are applying the intervention in their
daily work or not. In this study, unfortunately, most of
the participating organizations did not implement all
proposed preventive measures; although they indicated
that they would try to do so at recruitment in the study.
The advised package of interventions as a whole was
accepted by only one of the seven participating organiza-
tions. The other organizations chose parts of the pro-
posed intervention plan, while two organizations even
decided to do nothing at all. As a consequence, many
workers who should have received an intervention were
never offered one, let alone participated in one. This may
have added to the limited cost-effectiveness of the RSI
QuickScan intervention programme. Which factors
impeded the implementation of the interventions will be
investigated in a process evaluation. However, the main
reason given by the organizations was that their available
Table 5 Mean costs for the intervention and usual care group and the difference in mean costs from an employer’s
perspective
Total direct costs Intervention (n = 320)
Mean (SD)
Usual care (n = 318)
Mean (SD)
Intervention - Usual care
Difference in costs
Mean (95% CI)
2
Total intervention costs
3 58.97 (84.74) 28.24 (56.11) 30.73 (18.78; 41.03)
Mean costs per person for the intervention and usual care group and the difference in mean costs (€, 2006 values
1) between both groups over 12 months.
1 € = US $1.27;
2 95% confidence interval obtained by bias-corrected and accelerated bootstrapping with 2000 replications;
3 prices according to the professional
organisation (Occupational Health Service - Arbo Unie).
Table 6 Total direct costs, effects and the difference in mean costs from a societal perspective
Intervention
Mean (SD)
Usual care
Mean (SD)
Intervention - Usual care
Difference costs and effects
Mean (95% CI)
2
information (N = 320) (N = 318)
Total direct costs 166.82 (436.96) 135.73 (294.55) 31.09 (-26.70; 88.88)
Effects (range 0 - 1) -0.22 (0.51) -0.10 (0.47) -0.11 (-0.19; -0.04)
work posture and movement (N = 315) (N = 317)
Total direct costs 169.23 (440.00) 136.11 (294.94) 33.12 (-25.32; 91.56)
Effects (range 0 - 11) -0.96 (1.89) -0.61 (2.00) -0.35 (-0.66; -0.05)
arm, neck, shoulder symptoms (N = 312) (N = 308)
Total direct costs 170.55 (441.91) 128.11 (276.04) 42.44 (-15.48; 100.36)
Effects (range 0 - 44) -1.36 (5.49) -0.77 (5.92) -0.59 (-1.48; 0.31)
sick leave from paid labour (N = 320) (N = 318)
Total direct costs 166.82 (436.96) 135.73 (294.55) 31.09 (-26.70; 88.88)
Effects (days of sick leave) 0.14 (23.71) -0.30 (23.970) 0.44 (-3.26; 4.14)
Benefits
3 (costs of sick leave) 307.71 (3122.17) 227.51 (2847.64) 80.20 (-383.45; 543.86)
Total direct costs and effects per person for the intervention and usual care group and the difference in mean costs (€, 2006 values
1) between both groups from
a societal perspective. Mean costs and effects for the scales “information”, “work posture and movement” and “arm, neck, shoulder symptoms are presented over
a 12 months period. A negative effect value for these risk factors represents a reduction in exposure and the desired effect. Mean costs and effects for days- and
costs of sick leave are presented over a 6 months period. A positive effect or benefit value for sick leave represents an increase in days or costs of sick leave and
an undesired effect.
1 € = US $1.27;
2 95% confidence interval obtained by bias-corrected and accelerated bootstrapping with 5000 replications;
3 Indirect costs
for paid labour were calculated according to the friction cost approach on the basis of the mean income of the Dutch population stratified for age and
gender [17].
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Page 8 of 13Figure 1 Cost-effectiveness plane for “Information”. Intervention versus usual care; range 0 - 1. The individual points on the plane represent
5000 bootstrapped cost-effect pairs using the bias-corrected percentile method. The central black dot indicates the point estimate of the
incremental cost-effectiveness ratio.
Figure 2 Cost-effectiveness plane for “Work posture and movement”. Intervention versus usual care; range 0-11. The individual points on
the plane represent 5000 bootstrapped cost-effect pairs using the bias-corrected percentile method. The central black dot indicates the point
estimate of the incremental cost-effectiveness ratio.
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Page 9 of 13Figure 3 Cost-effectiveness plane for the prevalence of arm, shoulder and neck symptoms - total symptom score. Intervention versus
usual care; range 0 - 44. The individual points on the plane represent 5000 bootstrapped cost-effect pairs using the bias-corrected percentile
method. The central black dot indicates the point estimate of the incremental cost-effectiveness ratio.
Figure 4 Cost-effectiveness plane for days of sick leave. The individual points on the plane represent 5000 bootstrapped cost-effect pairs
using the bias-corrected percentile method. The central black dot indicates the point estimate of the incremental cost-effectiveness ratio.
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Page 10 of 13budget for these interventions was insufficient. Further
strengths and weaknesses of the cluster randomized trial
have been described extensively elsewhere [6].
Presenteeism
In this study, productivity loss was measured by sick
leave. Presenteeism, when the employee is at work, but
not fully productive, was not included. Loss of produc-
tivity as a result of presenteeism, due to arm, shoulder
and neck symptoms, constitutes a substantial economic
burden to employers in the Netherlands [4]. The pro-
ductivity in the case of presenteeism may vary from a
relatively small decrease in productivity, to a total loss
of productivity. In a study by Martimo et al [26], work-
ers with arm, shoulder and neck symptoms, on average,
lost one third of their regular productivity, which in a
normal work day would correspond to 2.5 hours of lost
working time. In the RSI QuickScan questionnaire the
workers were asked to indicate on a scale from 1 to 10
how efficiently they worked on days when they were at
work, but were suffering from neck, shoulder and arm
symptoms. Unfortunately, the workers were not asked
to quantify the duration of this period, which makes it
impossible to estimate the associated costs. Conse-
quently, cost of productivity loss in this study may have
been underestimated [27].
Sensitivity analysis
A sensitivity analysis is an important feature in economic
evaluations, since study results can be sensitive to the
values assumed for by key parameters [22]. The parameters
concerning the direct health care costs were estimated
according to the prices in the Dutch manual for costing in
economic evaluations and adjusted to calendar year 2006
[17]. This manual describes a uniform costing methodol-
ogy, which makes it easier to interpret and compare stu-
dies. The prices in the manual are widely accepted and
used for cost-effectiveness studies in the Netherlands. The
parameters for intervention costs were the actual prices
according to the occupational health service that provided
the services. These prices are suitable for use since there is
a well functioning, competitive occupational health care
market in the Netherlands and the used market prices are
not subsidized, nor have they got a high profit margin.
In this study, physical and alternative therapy, such as
Cesar/Mensendieck exercise therapy, were the most
used health care resources in both groups, with the
highest cost. This is quite common in the Netherlands.
Approximately 13% of the Dutch population is receiving
physical therapy once per year, with an average of 18
visits per person [28].
Imputation of missing cost data for medicine use and
increasing the costs of private purchases of specific
Figure 5 Cost-effectiveness plane for sick leave costs. The individual points on the plane represent 5000 bootstrapped cost-effect pairs using
the bias-corrected percentile method. The central black dot indicates the point estimate of the incremental cost-effectiveness ratio.
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Page 11 of 13products/tools aimed at reducing neck, shoulder and
arm symptoms in the sensitivity analyses did not change
the conclusions of this economic evaluation.
Comparison with other studies
Studies evaluating the (cost-) effectiveness of interven-
tions aimed at reducing arm, shoulder and neck symp-
toms are scarce [7-9] and no other cost-effectiveness
study, in which an advised set of interventions is based
on a previously established risk profile, was found in the
literature. Therefore, this article provides new informa-
tion for decision makers and occupational health profes-
sionals on the effectiveness and cost-effectiveness of such
an intervention strategy for computer workers. Unfortu-
nately, since no similar cost-effectiveness study was
found in the literature, the evidence on the lack of effec-
tiveness of this strategy is limited. Still, a few studies on
the cost-effectiveness of preventive interventions aimed
at reducing arm, shoulder or neck symptoms, in different
working populations, have been published in the last dec-
ade. A study by Yeow et al [29] on the cost-effectiveness
of simple and inexpensive ergonomic improvements in
test workstations of an electronics factory, found average
savings in yearly rejection cost (i.e. costs as a results of
customers returning defect products), reduction in rejec-
tion rate, increase in monthly revenue, improvements in
productivity and other benefits. Even though the setting
of Yeow’s study, an assembly factory in an industrially
developing country, was quite different from ours, one of
the implemented ergonomic interventions, an optimiza-
tion of the workstation design, was also one of the inter-
ventions used in our study. Several other randomized
controlled trials have shown some promising results, but
did not include a cost-effectiveness analysis. A study by
Ketola et al [30] that evaluated the effect of an intensive
ergonomic approach and education on workstation
changes and musculoskeletal disorders among computer
workers, found that both the intensive ergonomics
approach and education in ergonomics did help to
reduce discomfort in computer work. A study by Bohr
[31] found that computer workers who received educa-
tion reported less pain/discomfort and psychosocial work
stress following the intervention than those who did not
receive education.
Conclusions
In conclusion, the RSI QuickScan intervention pro-
gramme was not cost-effective compared to usual care.
This might be caused by the fact that a large percentage
of workers did not receive the advised intervention. For
those who did receive an intervention, the duration and
intensity of the interventions was often low. However,
the programme did increase the number of workers
who received information on healthy computer use and
improved their work posture and movement at relatively
modest costs.
Additional material
Additional file 1: RSI QuickScan questionnaire. The file provides a
detailed description of the content of the RSI QuickScan questionnaire.
Additional file 2: Interventions in the RSI QuickScan intervention
programme. The file provides a description of all 16 interventions that
were part of the RSI QuickScan intervention programme.
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